Injured tubule-derived NOV drives pro-inflammatory macrophage activation through NOTCH1/RBPJ signaling in acute kidney injury

Read full text
Authors: Yanlu Xin, G Chen, Ningxin Zhang, Xiao Sun, Wang Liting, Song Zhuo, Minghao Gu, Tianyang Li, L H Xu, X G Wang, Yanfei Wang, Lin Che
+3 more Long Zhao, Xuefei Shen, Yan Xu
Cited by: 1
References: 28

Abstract

Tubular–immune crosstalk contributes to acute kidney injury (AKI), but the mediators involved in this process remain incompletely understood. Nephroblastoma overexpressed (NOV/CCN3), a secreted matricellular protein, may participate in inflammatory responses during ischemia–reperfusion (I/R)-induced AKI. Serum NOV was measured in cardiac surgery patients with or without postoperative AKI. Renal I/R models, recombinant NOV administration, AAV-mediated tubular NOV knockdown, bone marrow-derived macrophages (BMDMs), co-immunoprecipitation, AlphaFold structural modeling, and DAPT-mediated NOTCH inhibition were used to examine the role and mechanism of NOV. Serum NOV was elevated in postoperative AKI patients. In I/R-AKI mice, injured tubular epithelial cells were associated with extracellular NOV accumulation. Recombinant NOV aggravated renal dysfunction and inflammation and promoted pro-inflammatory macrophage infiltration, whereas AAV-mediated NOV knockdown attenuated these responses. In BMDMs, NOV enhanced macrophage inflammatory activation and migration. Mechanistically, NOV-mediated macrophage responses were associated with NOTCH1/RBPJ signaling, and these effects were partially attenuated by the NOTCH inhibitor DAPT. Tubular-derived NOV promotes macrophage inflammatory activation via NOTCH1/RBPJ signaling, identifying NOV as a candidate pathway linking tubular injury to macrophage activation in ischemic AKI.

Fields of Study & Subjects

Connective Tissue Growth Factor Research Acute Kidney Injury Research Chronic Kidney Disease and Diabetes

Publication details

Journal / source
European journal of medical research
Publisher
Springer Science and Business Media LLC
Volume
31
Issue
1
Publication date
2 July 2026
Language
EN